| Ketamine treatment for refractory anxiety: A systematic review JL Tully, AD Dahlén, CJ Haggarty, HB Schiöth, S Brooks British journal of clinical pharmacology 88 (10), 4412-4426, 2022 | 33 | 2022 |
| Review of the neural processes of working memory training: Controlling the impulse to throw the baby out with the bathwater SJ Brooks, R Mackenzie-Phelan, J Tully, HB Schiöth Frontiers in psychiatry 11, 512761, 2020 | 28 | 2020 |
| Estimated prevalence, effects and potential risks of substances used for cognitive enhancement J Tully, C Montgomery, LJ Maier, HR Sumnall Human Enhancement Drugs, 112-127, 2019 | 6 | 2019 |
| Exploring the aetiology and effects of pharmacological cognitive enhancement use in UK university students JL Tully PQDT-Global, 2020 | 1 | 2020 |
| The rising use of cognitive enhancement drugs and predictors of use during COVID-19: findings from a cross-sectional survey of students and university staff in the UK JL Tully, O Bridge, J Rennie, J Krecké, T Stevens Frontiers in Psychology 15, 1-14, 2024 | | 2024 |
| Introduction and Afterword - Substance Use for Cognitive Enhancement JL Tully Chemically Modified Minds, 175-179, 2020 | | 2020 |
Helgi SchiöthProfessor at Department of Neuroscience, Functional Pharmacology, Uppsala University在 neuro.uu.se 的电子邮件经过验证
